Cubilin P1297L mutation associated with hereditary megaloblastic anemia 1 causes impaired recognition of intrinsic factor–vitamin B12 by cubilin

M Kristiansen, M Aminoff, C Jacobsen… - Blood, The Journal …, 2000 - ashpublications.org
M Kristiansen, M Aminoff, C Jacobsen, A De La Chapelle, R Krahe, PJ Verroust…
Blood, The Journal of the American Society of Hematology, 2000ashpublications.org
Abstract Megaloblastic anemia 1 (MGA1) is an autosomal recessive disorder caused by the
selective intestinal malabsorption of intrinsic factor (IF) and vitamin B12/cobalamin (Cbl) in
complex. Most Finnish patients with MGA1 carry the disease-specific P1297L mutation
(FM1) in the IF-B12 receptor, cubilin. By site-directed mutagenesis, mammalian expression,
and functional comparison of the purified wild-type and FM1 mutant forms of the IF–Cbl-
binding cubilin region (CUB domains 5-8, amino acid 928-1386), we have investigated the …
Abstract
Megaloblastic anemia 1 (MGA1) is an autosomal recessive disorder caused by the selective intestinal malabsorption of intrinsic factor (IF) and vitamin B12/cobalamin (Cbl) in complex. Most Finnish patients with MGA1 carry the disease-specific P1297L mutation (FM1) in the IF-B12 receptor, cubilin. By site-directed mutagenesis, mammalian expression, and functional comparison of the purified wild-type and FM1 mutant forms of the IF–Cbl-binding cubilin region (CUB domains 5-8, amino acid 928-1386), we have investigated the functional implications of the P1297L mutation. Surface plasmon resonance analysis revealed that the P1297L substitution specifically increases the Kd for IF–Cbl binding several-fold, largely by decreasing the association rate constant. In agreement with the binding data, the wild-type protein, but not the FM1 mutant protein, potently inhibits 37°C uptake of iodine 125–IF–Cbl in cubilin-expressing epithelial cells. In conclusion, the data presented show a substantial loss in affinity of the FM1 mutant form of the IF–Cbl binding region of cubilin. This now explains the malabsorption of Cbl and Cbl-dependent anemia in MGA1 patients with the FM1 mutation.
ashpublications.org